SP
Strategikon Pharma, Inc.
SEC filingOther Technology · San Francisco, CA
Amount raised$2.3Msold at filing
Total offering$3M$708K still open
Investors in the raise15count reported to the SEC
FiledNov 21, 2025first sale May 8, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Rob HessDirector
Anca CopaescuExecutive Officer, Director
Debra ApruzzeseDirector
Chris CodeanneDirector
Paulo CarvalhoExecutive Officer
Vincent LepreuxDirector
Mark WeinsteinExecutive Officer, Director
Nathanael LentzDirector
Executive officers, directors and promoters as listed on the Form D.